Article
Pyrazinamide triggers degradation of its target aspartate decarboxylase
2019-06-18
Abstract excerpt
The introduction of pyrazinamide (PZA) in the tuberculosis drug regimen shortened treatment from 12 to 6 months 1 . PZA is a prodrug that is activated by a Mycobacterium tuberculosis (Mtb) amidase to release its bioactive component pyrazinoic acid (POA) 2 . Aspartate decarboxylase PanD, a proenzyme activated by autocatalytic cleavage (Supplementary Fig. 1A, 3 ) and required for Coenzyme A (CoA) biosynthesis, e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eebe0430-6c1a-5d4a-973a-6b8ce06bcf6a
- DOI
- 10.1101/674416
